Category Specific RSS

HMD

HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use

It may only be a matter of time until expectant mothers can monitor the heartbeats of their unborn child from…

10 months ago

Promising results emerge for HeraMED’s telehealth solution for antenatal care

With the rapid acceleration of telehealth solutions brought about by the pandemic, one company is uniquely servicing a key demographic-…

4 years ago

1 in 4 babies in the US benefit from HeraMed’s pregnancy tech

Medical data and technology company HeraMED (ASX: HMD) has today announced a partnership to accelerate their mission to revolutionise maternal…

4 years ago

High-touch, high-quality maternity care could soon become standard in major hospitals

Bringing telehealth to expectant mothers that will rival major hospital facilities, medtech company HeraMED (ASX: HMD) is taking a significant…

4 years ago

HeraMED to rollout telehealth maternity care in the lucrative U.S market

Prior to COVID-19 bringing attention to the value of telehealth, HeraMED (ASX: HMD) has been building digital infrastructure to revolutionise…

5 years ago

HeraMED shares surge 51% following FDA approval for fetal heart monitor

Medtech company HeraMED (ASX: HMD) has seen a major spike in investor confidence after securing clearance from the US Food…

6 years ago